Acticor Biotech Alternatives & Competitors
12 companies similar to Acticor Biotech — To treat the acute phase of ischemic stroke !
Companies similar to Acticor Biotech
Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
PrecisemAb Biotech Co., Ltd.
We are committed to changing the world to be better by creating safer and disease-directed...
Zhimeng Biopharma
Actively advancing innovative small molecule treatments for neurological conditions like e...
Rival Readout
Competing with Acticor Biotech? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Algiax Pharmaceuticals
Disarming chronic neuropathic pain
Myrobalan Therapeutics
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...
ImmunAbs Inc.
ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope f...
Zura Bio Limited (Nasdaq: ZURA)
Developing novel medicines for severe immune disorders
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
About Acticor Biotech
Acticor Biotech, a spin-off from Inserm (French National Institute of Health and Medical Research), is focused on developing an innovative therapeutic strategy for the acute phase of ischemic strokes, which constitute 80% of all strokes. The company's project addresses the pressing need for new therapeutic options to m...
Drug development for thrombotic diseases
Patients suffering from acute ischemic stroke and cardiovascular emergencies
Biopharmaceuticals, Stroke Treatment, Thrombosis Therapy, Acute Phase Drug, Monoclonal Antibody, Drug Development, Innovative Therapy, Neurological Disorders, Biotechnology Research, Medical Research, Biomedical Science, Pharmaceutical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Acticor Biotech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Acticor Biotech on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.